ArticleNeoplasia (New York, N.Y.)2006

Signaling from p53 to NF-kappa B determines the chemotherapy responsiveness of neuroblastoma.

Michael B Armstrong et al.PubMed ↗Full text ↗

No numbers read from the abstract.